Literature DB >> 16376082

Steric interactions and the activity of fentanyl analogs at the mu-opioid receptor.

Ljiljana Dosen-Micovic1, Milovan Ivanovic, Vuk Micovic.   

Abstract

Fentanyl is a highly potent and clinically widely used narcotic analgesic. The synthesis of its analogs remains a challenge in the attempt to develop highly selective mu-opioid receptor agonists with specific pharmacological properties. In this paper, the use of flexible molecular docking in a study of the formation of complexes between a series of active fentanyl analogs and the mu-opioid receptor is described. The optimal position and orientation of fourteen fentanyl analogs in the binding pocket of the mu-receptor were determined. The major receptor amino acids and the ligand functional groups participating in the complex formation were identified. Stereochemical effects on the potency and binding are explained. The proposed model of ligand-receptor binding is in agreement with point mutation experiments explaining the role of the amino acids: Asp147, Tyr148, Asn230, His297, Trp318, His319, Cys321, and Tyr326 in the complex formation. In addition, the following amino acids were identified as being important for ligand binding or receptor activation: Ile322, Gly325, Val300, Met203, Leu200, Val143, and Ile144.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16376082     DOI: 10.1016/j.bmc.2005.12.010

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

Review 1.  Recent Advances in Peripheral Opioid Receptor Therapeutics.

Authors:  Raghav Seth; Sumanth S Kuppalli; Danielle Nadav; Grant Chen; Amitabh Gulati
Journal:  Curr Pain Headache Rep       Date:  2021-05-10

Review 2.  Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications.

Authors:  Ruben S Vardanyan; Victor J Hruby
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

Review 3.  Neurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance.

Authors:  Christopher L Rees; Charise M White; Giorgio A Ascoli
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

4.  A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor.

Authors:  Bing Xie; Alexander Goldberg; Lei Shi
Journal:  Comput Struct Biotechnol J       Date:  2022-05-14       Impact factor: 6.155

Review 5.  [Pain inhibition by opioids-new concepts].

Authors:  C Stein
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

6.  Molecular dynamics of fentanyl bound to μ-opioid receptor.

Authors:  Piotr F J Lipiński; Małgorzata Jarończyk; Jan Cz Dobrowolski; Joanna Sadlej
Journal:  J Mol Model       Date:  2019-05-03       Impact factor: 1.810

7.  Identification, structure-activity relationships and molecular modeling of potent triamine and piperazine opioid ligands.

Authors:  Austin B Yongye; Jon R Appel; Marc A Giulianotti; Colette T Dooley; Jose L Medina-Franco; Adel Nefzi; Richard A Houghten; Karina Martínez-Mayorga
Journal:  Bioorg Med Chem       Date:  2009-06-21       Impact factor: 3.641

8.  Efficacy and safety of fentanyl buccal for cancer pain management by administration through a soluble film: an update.

Authors:  Marvin Omar Delgado-Guay
Journal:  Cancer Manag Res       Date:  2010-11-24       Impact factor: 3.989

9.  Intranasal fentanyl for pain control: current status with a focus on patient considerations.

Authors:  Eric Prommer; Lisa Thompson
Journal:  Patient Prefer Adherence       Date:  2011-03-18       Impact factor: 2.711

10.  Xylazine as a drug of abuse and its effects on the generation of reactive species and DNA damage on human umbilical vein endothelial cells.

Authors:  Luz Silva-Torres; Christian Veléz; Lyvia Alvarez; Beatriz Zayas
Journal:  J Toxicol       Date:  2014-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.